Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hims & Hers Health, Inc.HIMS · Entity 1878 | Director · Chief Executive Officer · 10% owner | August 25, 2026 | August 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hims & Hers Health, Inc.
Report date August 25, 2026 · Filed August 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of AD 2022 GRAT | 0 |
Reported balance
After 2026-08-25 transaction · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · 2026-08-25 · Gift · Disposed 463,289 · Balance 0 F2: The reported transaction involves a transfer of securities by bona fide gift for which no payment of consideration was received by the Reporting Person. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of AD 2022 GRAT | 463,289 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 463,289 F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of Dudum Legacy 2021 Trust | 103,406 |
Reported balance
After 2026-08-27 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2026-08-27 · Other · Disposed 977,566 · Balance 103,406 F3: This transaction represents a pro rata distribution, for no consideration, by the trust to its beneficiaries, of an aggregate of 977,566 shares of Class A Common Stock for bona fide estate planning purposes. |
| Class A Common StockSEC Table I · non-derivative | Direct | 1,033,177 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,033,177 |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 | 573,202 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 573,202 F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of AD 2025 GRAT dated 5-27-2025 | 42,993 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 42,993 |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of Dudum Family Community Property Trust | 470,457 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 470,457 |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of AD 2022 GRAT 2 dated 9/7/2022 | 791,117 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 8
Holding and transaction disclosures are not merged.
1 source rowRow 8 · Balance 791,117 |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of Dudum Family Heritage Trust UAD 8-10-2021 | 2,214,769 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 9
Holding and transaction disclosures are not merged.
1 source rowRow 9 · Balance 2,214,769 |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of Dudum Family 2021 Trust | 3,004,071 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 10
Holding and transaction disclosures are not merged.
1 source rowRow 10 · Balance 3,004,071 |
Filing footnotes · ownership attribution and instrument terms
F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT.
F2: The reported transaction involves a transfer of securities by bona fide gift for which no payment of consideration was received by the Reporting Person.
F3: This transaction represents a pro rata distribution, for no consideration, by the trust to its beneficiaries, of an aggregate of 977,566 shares of Class A Common Stock for bona fide estate planning purposes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 16, 2025 Filed Jan 21, 2025 21:13 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 6,981 | $27.28 | $190,417.25 |
DisclosureSEC source: 0001773751-25-000012 · wk-form4_1737494017.xml · nonDerivative · entry 7 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust Disclosed balance after: 475,330 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.125 - $28.105. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 16, 2025 Filed Jan 21, 2025 21:13 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 40,553 | $26.96 | $1,093,467.04 |
DisclosureSEC source: 0001773751-25-000012 · wk-form4_1737494017.xml · nonDerivative · entry 6 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust Disclosed balance after: 482,311 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.72 - $27.12. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 16, 2025 Filed Jan 21, 2025 21:13 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 1,100 | $27.40 | $30,138.46 |
DisclosureSEC source: 0001773751-25-000012 · wk-form4_1737494017.xml · nonDerivative · entry 5 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,918 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.12 - $28.105. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 16, 2025 Filed Jan 21, 2025 21:13 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 1,692 | $27.04 | $45,753.20 |
DisclosureSEC source: 0001773751-25-000012 · wk-form4_1737494017.xml · nonDerivative · entry 4 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,018 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.01 - $27.085. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 16, 2025 Filed Jan 21, 2025 21:13 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 7,753 | $27.22 | $211,041.31 |
DisclosureSEC source: 0001773751-25-000012 · wk-form4_1737494017.xml · nonDerivative · entry 3 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,710 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.12 - $28.105. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 16, 2025 Filed Jan 21, 2025 21:13 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 25,915 | $27.03 | $700,596.48 |
DisclosureSEC source: 0001773751-25-000012 · wk-form4_1737494017.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,463 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.70 - $27.115. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 16, 2025 Filed Jan 21, 2025 21:13 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 33,668 | $2.43 | $81,813.24 |
DisclosureSEC source: 0001773751-25-000012 · wk-form4_1737494017.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,378 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. Read SEC document |
| January 16, 2025 Filed Jan 23, 2025 21:30 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 16,667 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-25-000014 · wk-form4a_1737667801.xml · derivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,548,068 Underlying: Class A Common Stock · 16,667 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The form is being revised to show the correct option award being used for this transaction. F2 · kind: The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F4 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020. Read SEC document |
| January 16, 2025 Filed Jan 23, 2025 21:30 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 17,001 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-25-000014 · wk-form4a_1737667801.xml · derivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 170,014 Underlying: Class A Common Stock · 17,001 shares Expires 2030-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The form is being revised to show the correct option award being used for this transaction. F2 · kind: The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F3 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. Read SEC document |
| December 17, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 10,539 | $32.63 | $343,931.83 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · nonDerivative · entry 13 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,710 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F11 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $32.58 - $32.77. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 17, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 68,707 | $32.01 | $2,199,187.40 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · nonDerivative · entry 12 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,249 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F10 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $31.58 - $32.56. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 17, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 10,539 | $32.63 | $343,931.83 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · nonDerivative · entry 13 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,710 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F11 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $32.58 - $32.77. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 17, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 68,707 | $32.01 | $2,199,187.40 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · nonDerivative · entry 12 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,249 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F10 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $31.58 - $32.56. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 41,667 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · derivative · entry 33 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,564,735 Underlying: Class A Common Stock · 41,667 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F18 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 16,667 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · derivative · entry 32 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,606,402 Underlying: Class A Common Stock · 16,667 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F18 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 17,001 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · derivative · entry 31 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 187,015 Underlying: Class A Common Stock · 17,001 shares Expires 2030-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F17 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 41,667 | $30.35 | $1,264,422.62 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · nonDerivative · entry 11 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,956 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F9 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $30.00 - $30.72. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 41,667 | $2.43 | $101,250.81 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · nonDerivative · entry 10 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 151,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 16,667 | $28.79 | $479,797.93 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · nonDerivative · entry 9 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,956 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F8 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.51 - $29.21. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 16,667 | $2.43 | $40,500.81 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · nonDerivative · entry 8 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 126,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 17,001 | $28.78 | $489,372.08 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · nonDerivative · entry 7 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,956 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F7 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.50 - $29.12. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 17,001 | $2.43 | $41,312.43 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · nonDerivative · entry 6 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 126,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 15,600 | $29.78 | $464,516.52 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · nonDerivative · entry 5 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust Disclosed balance after: 522,864 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.505 - $30.22. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 31,934 | $28.89 | $922,451.91 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · nonDerivative · entry 4 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust Disclosed balance after: 538,464 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.51 - $29.50. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 2,792 | $28.87 | $80,603.64 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · nonDerivative · entry 3 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,956 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.68 - $29.03. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 41,667 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · derivative · entry 24 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,564,735 Underlying: Class A Common Stock · 41,667 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F17 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 16,667 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · derivative · entry 23 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,606,402 Underlying: Class A Common Stock · 16,667 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F17 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 17,001 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · derivative · entry 22 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 187,015 Underlying: Class A Common Stock · 17,001 shares Expires 2030-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F16 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 41,667 | $30.35 | $1,264,422.62 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · nonDerivative · entry 11 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,956 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F9 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $30.00 - $30.72. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 41,667 | $2.43 | $101,250.81 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · nonDerivative · entry 10 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 151,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 16,667 | $28.79 | $479,797.93 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · nonDerivative · entry 9 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,956 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F8 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.51 - $29.21. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 16,667 | $2.43 | $40,500.81 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · nonDerivative · entry 8 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 126,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 17,001 | $28.78 | $489,372.08 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · nonDerivative · entry 7 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,956 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F7 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.50 - $29.12. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 17,001 | $2.43 | $41,312.43 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · nonDerivative · entry 6 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 126,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 15,600 | $29.78 | $464,516.52 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · nonDerivative · entry 5 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust Disclosed balance after: 522,864 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.505 - $30.22. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 31,934 | $28.89 | $922,451.91 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · nonDerivative · entry 4 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust Disclosed balance after: 538,464 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.51 - $29.50. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 2,792 | $28.87 | $80,603.64 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · nonDerivative · entry 3 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,956 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.68 - $29.03. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 74,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · derivative · entry 30 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 968,888 Underlying: Class A Common Stock · 74,530 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F16 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. F16 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18,289 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · derivative · entry 29 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,289 Underlying: Class A Common Stock · 18,289 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F15 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F15 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 1,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · derivative · entry 28 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,789 Underlying: Class A Common Stock · 1,789 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F15 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F15 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 3,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · derivative · entry 27 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,576 Underlying: Class A Common Stock · 3,575 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F15 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F15 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 107 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · derivative · entry 26 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108 Underlying: Class A Common Stock · 107 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F15 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F15 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 7,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · derivative · entry 25 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,330 Underlying: Class A Common Stock · 7,330 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F15 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F15 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 35,242 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · derivative · entry 24 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 176,210 Underlying: Class A Common Stock · 35,242 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F14 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022. F14 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 35,446 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · derivative · entry 23 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 319,019 Underlying: Class A Common Stock · 35,446 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F13 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. F13 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 97,062 | $30.02 | $2,913,801.24 |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,748 F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:57 UTC Amendment | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 176,308 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-24-000403 · wk-form4a_1734483454.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 209,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 74,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · derivative · entry 21 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 968,888 Underlying: Class A Common Stock · 74,530 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F15 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. F15 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18,289 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · derivative · entry 20 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,289 Underlying: Class A Common Stock · 18,289 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F14 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F14 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 1,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · derivative · entry 19 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,789 Underlying: Class A Common Stock · 1,789 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F14 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F14 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.